The Effect of Globalization on Economic Development Indicators: An Inter-Regional Approach

Cervantes, Pedro Antonio Martín; López, Nuria Rueda; Rambaud, Salvador Cruz

doi:10.3390/su12051942

Cited by 13 publications

(6 citation statements)

References 80 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…China has made remarkable progress in recent decades, with about 80% of deaths caused by chronic diseases and high exposure to risk factors (high male tobacco consumption, a significant proportion of children aged 7–17 in large cities are overweight or obese) [ 37 , 38 ]. An interesting aspect is also the relationship between globalisation and government spending on health or quality of life, with countries with highly globalised economies (such as China) clustering with developed Western countries [ 39 ], which may be an original and novel element of the proposed study.…”

Section: Resultsmentioning

confidence: 99%

Mortality Trends by Causes of Death and Healthcare during a Period of Global Uncertainty (1990–2017)

et al. 2021

View full text Add to dashboard Cite

In this study we aim to highlight the spatial differences, intensity and frequency of causes of death associated with a range of diseases and the implications of the socio-economic impact on healthcare worldwide between 1990 and 2017: (1) Background: At the same time, an attempt was made to find regional spatial patterns that may be typical for a given geographical area, based on the assumption that global health care is in a permanent state of uncertainty as developed countries have a different morbidity profile than emerging or developing countries. (2) Methods: Using information provided by Global Burden of Disease Collaborative Network, Our World in Data and the World Bank, a multidimensional analysis was carried out, comprising four types of statistical models: grouping analysis, principal component analysis (PCA) Bravais–Pearson linear correlation and multivariate regression. (3) Results: The results confirm the hypothesis of significant correlations between the frequency of causes of death, quality of health care and quality of public health infrastructure, validated by incidence with socio-economic indicators. The study contributes to the literature by analysing trends in the spatial distribution of causes of death worldwide, detecting regional differentiations and testing how socio-economic factors may limit the incidence of morbidity.

show abstract

Section: Resultsmentioning

confidence: 99%

Mortality Trends by Causes of Death and Healthcare during a Period of Global Uncertainty (1990–2017)

et al. 2021

View full text Add to dashboard Cite

show abstract

“…The included countries were Germany, the UK, Canada, the USA, Islamic republic of Iran and Ethiopia. Countries were selected based on the following criteria [ 22–28 ] : Ethiopia is selected to represent low‐income countries with no pharmaceutical price regulation system. Iran is selected to represent upper middle‐income countries with pharmaceutical price regulation system. The USA is selected to represent capitalism‐based health system with no pharmaceutical price regulation system. Germany is selected to represent high‐income countries with social insurance‐based health system and pharmaceutical price regulation system. The UK is selected to represent high‐income countries with social insurance‐based health system and specific pharmaceutical price control system (profit sharing). Canada is selected to represent high‐income countries with social insurance‐based health system and with a mixture of pharmaceutical price regulation systems. …”

Section: Methodsmentioning

confidence: 99%

Why healthcare market needs government intervention to improve access to essential medicines and healthcare efficiency: a scoping review from pharmaceutical price regulation perspective

Sorato

Davari

Asl

et al. 2020

Journal of Pharmaceutical Health Services Research

View full text Add to dashboard Cite

Background Access to quality essential medicines at affordable price to patients in the healthcare market is one of the main goals of universal health coverage and health‐related sustainable development goals. Healthcare market is imperfect, and the government cannot ensure access to essential medicines if the market is left to operate under invisible hand control. This scoping review was conducted with intention to provide the clear picture on impact of pharmaceutical price regulation on access to essential medicines, drug innovation and launching. Methods We searched articles written in the English language since January 2000 from PubMed, Embase, Scopus, Ovid/Medline and Google scholar with systematic search query. Results Access to essential medicines, which is defined in terms of availability, affordability, accessibility, acceptability and quality of drugs, can be improved by pharmaceutical price regulation. Countries can use different price regulation strategies based on their healthcare objectives and priority healthcare needs. Country‐specific pharmaceutical price regulation could not significantly affect drug innovation and launching. However, supportive strategies such as open public funding for drug innovation research, providing innovation awards and strong patent rights can counterbalance the effect of price regulation on innovation and drug development research in developed countries. Conclusion Regulating pharmaceutical pricing system is one of the key strategies to ensure access to essential medicines. Countries that have implemented pharmaceutical price regulation system (Germany, the UK, Canada and Iran) have achieved better access to essential medicines. However, the US and Ethiopian health systems that are unregulated concerning pharmaceutical pricing had a great challenge of affordability of essential medicines. Therefore, setting country‐specific pharmaceutical price regulation system along with additional strategies to improve drug innovation is critical to ensure access to essential medicines.

show abstract

“…Comparison across countries on their performance in various domains, as an essential element of globalization, has lately gained a prominent place in the public agenda. Numerous agencies create country rankings on indicators measuring an incredibly broad array of spheres—from the better known measures of economic affluence to the more general and less obviously quantifiable global influence and soft power and even the elusive realities of happiness and life satisfaction (Bérenger and Verdier-Chouchane, 2007; Cervantes et al, 2020; Ezell et al, 2016; Shelton, 2020). These national features are often depicted in national media sources.…”

Section: Introductionmentioning

confidence: 99%

Contrasting perspectives: Belief in national superiority in relation to countries’ performance

Fabrykant

Vladimir

2022

International Journal of Comparative Sociology

View full text Add to dashboard Cite

This article examines cross-country differences in the strength of individuals’ belief that their country is better than most others and the dependence of this belief on their country’s performance in various spheres. The research design consists of a series of multilevel ordinal logistic regression models estimated using the data of the most recent thematic wave of the International Social Survey Programme (ISSP)—National Identity module. Our research finds that these effects are mostly nonlinear U-shaped: people from both high- and low-performing countries express a strong belief in their country’s superiority, while people from average-performing countries do not. These findings suggest a bifurcated nature of belief in national superiority—an interplay between a grounded estimation of a country’s actual achievements and the social norms and individual motivations that prescribe holding one’s own country in high esteem regardless of its actual performance. These norms are found to be the strongest in underperforming countries, while in average- and high-performing countries, people making these evaluations are under weaker normative pressure and therefore more attuned to country achievements. As a result, the weakest belief in national superiority is found not in underperforming, but in average-performing countries. The latter also have the highest diversity on this belief, probably because different segments of the population compare their country’s performance against different benchmarks.

show abstract

The Effect of Globalization on Economic Development Indicators: An Inter-Regional Approach

Cited by 13 publications

References 80 publications

Mortality Trends by Causes of Death and Healthcare during a Period of Global Uncertainty (1990–2017)

Mortality Trends by Causes of Death and Healthcare during a Period of Global Uncertainty (1990–2017)

Why healthcare market needs government intervention to improve access to essential medicines and healthcare efficiency: a scoping review from pharmaceutical price regulation perspective

Contrasting perspectives: Belief in national superiority in relation to countries’ performance

Contact Info

Product

Resources

About